Physician profile
Zada K White
NPI 1427651157
$1,167.08
in general payments reported to CMS, 2019-2025
10 companies · $699 in 2025
The $699 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.48 · 2022: $17.04 · 2023: $23.08 · 2024: $413 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $415.30 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $338.80 | 2023-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $145.06 | 2024-2025 | Amvuttra |
| Inspire Medical Systems, INC. | $97.11 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $45.34 | 2025 | |
| Pfizer INC. | $36.07 | 2025 | |
| Abbvie INC. | $31.52 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.54 | 2024-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $15.09 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $13.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zada White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.